SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BELLINI, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.073
AS - Asia 8.930
EU - Europa 5.280
SA - Sud America 1.311
AF - Africa 216
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 13
Totale 30.846
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.749
SG - Singapore 3.272
CN - Cina 2.275
IT - Italia 1.210
BR - Brasile 1.018
VN - Vietnam 945
UA - Ucraina 804
DE - Germania 784
HK - Hong Kong 730
TR - Turchia 557
GB - Regno Unito 484
PL - Polonia 407
FI - Finlandia 369
FR - Francia 293
JP - Giappone 257
RU - Federazione Russa 238
BD - Bangladesh 237
SE - Svezia 227
IN - India 168
CA - Canada 154
MX - Messico 125
ID - Indonesia 111
AR - Argentina 105
NL - Olanda 88
ZA - Sudafrica 79
IQ - Iraq 60
BE - Belgio 53
ES - Italia 49
CO - Colombia 46
AT - Austria 43
CZ - Repubblica Ceca 41
EC - Ecuador 41
EE - Estonia 37
PK - Pakistan 34
VE - Venezuela 33
PH - Filippine 30
SA - Arabia Saudita 28
MY - Malesia 27
MA - Marocco 26
UZ - Uzbekistan 26
LT - Lituania 24
IR - Iran 22
CL - Cile 21
KR - Corea 20
AE - Emirati Arabi Uniti 19
PY - Paraguay 18
TN - Tunisia 18
AU - Australia 17
ET - Etiopia 17
KE - Kenya 16
NP - Nepal 16
EG - Egitto 15
BG - Bulgaria 14
DZ - Algeria 14
IE - Irlanda 14
AZ - Azerbaigian 12
JM - Giamaica 12
RO - Romania 12
UY - Uruguay 12
PE - Perù 11
CH - Svizzera 10
JO - Giordania 10
AL - Albania 9
EU - Europa 9
IL - Israele 9
PT - Portogallo 9
SD - Sudan 9
KZ - Kazakistan 8
AO - Angola 7
BY - Bielorussia 7
LB - Libano 7
OM - Oman 7
RS - Serbia 7
BO - Bolivia 6
DK - Danimarca 6
LV - Lettonia 6
PS - Palestinian Territory 6
TW - Taiwan 6
GE - Georgia 5
GR - Grecia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HN - Honduras 4
HU - Ungheria 4
KW - Kuwait 4
NI - Nicaragua 4
PA - Panama 4
BB - Barbados 3
DJ - Gibuti 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
QA - Qatar 3
TH - Thailandia 3
ZW - Zimbabwe 3
BA - Bosnia-Erzegovina 2
Totale 30.807
Salva come PNG Salva come JPEG
Città #
Singapore 2.104
Ashburn 1.534
Woodbridge 1.185
San Jose 1.136
Fairfield 986
Chandler 927
Jacksonville 884
Beijing 715
Houston 714
Hong Kong 712
Santa Clara 696
Ann Arbor 684
Wilmington 411
Warsaw 391
Seattle 362
Dallas 329
Izmir 312
Cambridge 299
Ho Chi Minh City 290
Nanjing 255
Tokyo 247
Ferrara 241
Los Angeles 240
Hanoi 217
Princeton 207
New York 200
Munich 185
Boardman 170
Lauterbourg 170
Milan 130
Helsinki 127
Dearborn 123
Council Bluffs 106
Nanchang 95
São Paulo 90
Shanghai 88
Shenyang 87
Mexico City 79
San Diego 77
Addison 74
Buffalo 70
London 68
Tianjin 67
Turku 66
Changsha 65
Jakarta 65
Bologna 64
Orem 64
Chennai 54
Rome 54
Toronto 53
Hebei 52
Bremen 50
Da Nang 50
Montreal 50
Chicago 49
Brussels 47
Brooklyn 46
Hefei 46
Jiaxing 46
Frankfurt am Main 42
Moscow 41
San Francisco 39
Haiphong 38
Phoenix 38
Johannesburg 37
Jinan 36
Denver 35
Brno 33
Norwalk 33
Stockholm 33
The Dalles 33
Orange 32
Poplar 32
Boston 31
Ningbo 31
Vienna 31
Atlanta 29
Manchester 29
Guangzhou 28
Rio de Janeiro 28
Curitiba 27
Redwood City 25
Hải Dương 23
Kunming 22
Amsterdam 21
Ankara 21
Baghdad 21
Mountain View 21
Tashkent 21
Auburn Hills 20
Augusta 20
Belo Horizonte 20
Charlotte 20
Leawood 20
Brasília 19
Zhengzhou 19
Düsseldorf 18
San Mateo 18
Dong Ket 17
Totale 20.107
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 413
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 323
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 302
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 275
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 252
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 250
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 248
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 246
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 245
Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study 239
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 237
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 236
Chimica Medica e propedeutica Biochimica 235
Evaluation of a possible role of oxidative stress in climacteric symptoms. 229
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 228
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 226
A rapid method for purification of myelin basic protein 224
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 223
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 221
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 215
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 213
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 207
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 206
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 206
Activation of the Sendai virus fusion protein by receptor binding 202
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 202
A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease 200
Activation of the sendai virus fusion protein by receptor binding 200
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 199
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 198
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 196
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 195
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 194
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 193
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 191
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 190
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 190
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 190
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 190
Mutual communication of envelope glycoproteins of paramixoviruses 189
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor 189
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 188
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 188
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 187
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 185
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 185
Analisi della proteina basica della mielina nel liquor 184
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 184
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 183
Le Metalloproteasi come potenziali marcatori biologici nella Sclerosi Multipla 182
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 182
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 181
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 180
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 180
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 179
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 176
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 175
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 174
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 173
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project 173
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 171
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 168
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 168
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 168
Biochemical study in adult population with stroke in Ferrara, Fabry disease 168
A catalytic tyrosine at the active site of sendai virus neuraminidase 166
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 166
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 165
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 165
null 163
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 162
Anomeric specificity of the neuraminidase from sendai virus 161
Evidence for multiple pairs of vicinal thiols in some proteins 158
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 157
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 156
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 156
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 155
Pain in head and neck cancer patients: The role of gender 155
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 155
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 154
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 152
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 152
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 152
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 151
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 150
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 150
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 149
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 148
Brain and serum cholesterol metabolism during perimenopausal transition: a risk factor for Alzheimer’s disease? 148
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 147
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 146
Gender differences in audio-vestibular disorders 146
The effect of inorganic phosphate on the stability of some enzymes 144
Rilevanza delle forme attive delle gelatinasi nel monitoraggio dell'attività della Sclerosi multipla 143
Domain structure of the hemagglutinin-neuraminidase from sendai virus 143
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 142
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 142
Purification of transglutaminase enzyme from L. infantum promastigotes 142
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 141
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 141
Totale 18.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 795
Totale 141.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 0 0 0 0 0 0 0 117
2021/20221.794 79 175 70 62 90 101 51 92 65 183 179 647
2022/20232.132 230 161 54 264 358 297 88 201 244 33 126 76
2023/2024952 98 121 62 25 95 89 25 66 30 23 28 290
2024/20254.210 119 78 375 164 528 329 142 246 650 565 564 450
2025/202612.233 1.119 552 1.168 1.547 1.634 781 1.458 660 1.147 1.329 540 298
Totale 31.182